glp-1 and antidepressants Medications: A Game Changer for Brain Health Beyond Weight Loss Study finds GLP-1 receptor agonist

Compounded GLP-1 medications are not FDA-approved and may only be prescribed when a licensed provider determines a clinically significant difference for an identified patient

Shanker G, Allen JW, Mutkus L, Aschner M (2001) Methylmercury inhibits cysteine uptake in cultured primary astrocytes, but not in neurons

Because the study was observational, it cannot establish a direct cause-and-effect relationship

However, older users often derive greater initial benefit making even partial retention valuable, while younger users might question whether modest improvements justify treatment investment when natural skin quality remains good